Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-17 09:22 am Purchase | 13G | ADMA BIOLOGICS INC. ADMA | STATE STREET CORP STT | 13,004,993 5.6% | 13,004,993 (New Position) | View |
| 2024-10-07 4:08 pm Purchase | 13G | ADMA BIOLOGICS INC. ADMA | BlackRock Inc. | 38,269,434 16.4% | 38,269,434 (New Position) | View |
| 2024-09-23 4:27 pm Sale | 13G | ADMA BIOLOGICS INC. ADMA | MILLENNIUM MANAGEMENT LLC | 1,374,038 0.6% | -4,880,371 (-78.03%) | View |
| 2024-03-11 12:31 pm Sale | 13G | ADMA BIOLOGICS INC. ADMA | TEACHERS ADVISORS LLC | 4,955,411 2.17% | -107,134 (-2.12%) | View |
| 2024-03-11 12:24 pm Sale | 13G | ADMA BIOLOGICS INC. ADMA | TIAA CREF INVESTMENT MANAGEMENT LLC | 4,955,411 2.17% | -107,134 (-2.12%) | View |
| 2024-03-11 12:19 pm Sale | 13G | ADMA BIOLOGICS INC. ADMA | Nuveen Asset Management LLC | 4,955,411 2.17% | -107,134 (-2.12%) | View |
| 2024-02-14 4:49 pm Sale | 13G | ADMA BIOLOGICS INC. ADMA | PERCEPTIVE ADVISORS LLC | 6,433,369 2.8% | -5,466,886 (-45.94%) | View |
| 2024-02-14 11:50 am Sale | 13G | ADMA BIOLOGICS INC. ADMA | Nuveen Asset Management LLC | 5,062,545 2.24% | -420,824 (-7.67%) | View |
| 2024-02-14 11:47 am Sale | 13G | ADMA BIOLOGICS INC. ADMA | TEACHERS ADVISORS LLC | 5,062,545 2.24% | -420,824 (-7.67%) | View |
| 2024-02-14 11:37 am Sale | 13G | ADMA BIOLOGICS INC. ADMA | TIAA CREF INVESTMENT MANAGEMENT LLC | 5,062,545 2.24% | -420,824 (-7.67%) | View |
| 2024-02-13 4:56 pm Purchase | 13G | ADMA BIOLOGICS INC. ADMA | VANGUARD GROUP INC | 12,891,875 5.71% | 12,891,875 (New Position) | View |
| 2024-01-26 11:49 am Purchase | 13G | ADMA BIOLOGICS INC. ADMA | BlackRock Inc. BLK | 17,917,745 7.9% | 2,816,464 (+18.65%) | View |
| 2023-02-14 2:31 pm Sale | 13G | ADMA BIOLOGICS INC. ADMA | PERCEPTIVE ADVISORS LLC | 11,900,255 5.4% | -33,132 (-0.28%) | View |
| 2023-02-14 08:50 am Purchase | 13G | ADMA BIOLOGICS INC. ADMA | Nuveen Asset Management LLC | 5,483,369 2.48% | 5,483,369 (New Position) | View |
| 2023-02-14 08:48 am Purchase | 13G | ADMA BIOLOGICS INC. ADMA | TEACHERS ADVISORS LLC | 5,483,369 2.48% | 5,483,369 (New Position) | View |
| 2023-02-14 08:47 am Purchase | 13G | ADMA BIOLOGICS INC. ADMA | TIAA CREF INVESTMENT MANAGEMENT LLC | 5,483,369 2.48% | 5,483,369 (New Position) | View |
| 2023-02-13 10:55 am Sale | 13G | ADMA BIOLOGICS INC. ADMA | Stonepine Capital Management LLC | 6,940,000 3.1% | -2,971,577 (-29.98%) | View |
| 2023-02-03 12:10 pm Purchase | 13G | ADMA BIOLOGICS INC. ADMA | BlackRock Inc. BLK | 15,101,281 6.9% | 9,347,461 (+162.46%) | View |
| 2022-12-09 5:00 pm Sale | 13D | ADMA BIOLOGICS INC. ADMA | Caligan Partners LP | 10,264,311 4.6% | -628,926 (-5.77%) | View |
| 2022-06-28 4:38 pm Purchase | 13G | ADMA BIOLOGICS INC. ADMA | MILLENNIUM MANAGEMENT LLC | 6,254,409 3.2% | 6,254,409 (New Position) | View |